Therapeutic recommendations for children with Hodgkin lymphoma
Official title: Therapeutic Recommendations for Children Registered in the RFAOP Register and With a Hodgkin Lymphoma
Run by French Africa Pediatric Oncology Group · NCT05407480 · Data updated 2026-11-12
This study is trying to create a standard treatment plan for children with Hodgkin lymphoma to improve their care and reduce the side effects of radiation therapy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Months to 18 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | French Africa Pediatric Oncology Group Academic / other |
| Drugs / interventions | radiation, chemotherapy |
| Locations | 1 site (Paris, France) |
| Status | Recruiting |
| Started | November 15, 2022 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2030 |
| Registry record updated | March 2, 2026 |
| Trial ID | NCT05407480 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children under 18 years of age diagnosed with classical Hodgkin lymphoma.
✕Probably not a fit
Patients over 18 years of age or those with a history of hematological malignancies or immune deficiencies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to standardize staging and therapeutic recommendations for pediatric patients diagnosed with classical Hodgkin lymphoma. It focuses on developing treatment protocols based on clinical, biological, and radiological data, particularly in regions with varying access to radiation therapy. The study will involve collaboration among various pilot units in African countries to ensure consistent and effective treatment approaches. The goal is to improve therapeutic outcomes while minimizing the long-term effects of radiation therapy.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols that enhance survival rates and reduce long-term side effects for children with Hodgkin lymphoma.
How similar studies have gone: Other studies have shown success in standardizing treatment protocols for pediatric cancers, indicating that this approach has potential for positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: under 18 years of age at diagnosis * suffering from "classical" Hodgkin's disease according to the WHO classification. * with no history of hematological malignancies or constitutional or acquired immune deficiencies Exclusion Criteria: * Over 18 years of age at diagnosis * A history of hematological malignancies or a history of constitutional or a history of acquired immune deficiencies
Where it's running
-
Brenda Mallon
Paris, France, France Recruiting
Study contacts
- Principal investigator: FATEN Ben Ayed, Professeur — French Africa Pediatric Oncology Group
- Study coordinator: Brenda MS MALLON
- Email: brenda.mallon@gustaveroussy.fr
- Phone: 0033 142115411
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FAPI-PET/CT imaging for diagnosing and staging pancreatic cancer
This study will try 18F‑FAPI‑74 PET/CT scans in adults with suspected or recurrent pancreatic cancer to see if they detect lymph node spread and distant metastases more accurately.
-
AI-guided ultrasound and MRI staging to guide bladder cancer treatment
This project will test whether a deep-learning system using ultrasound, MRI, and pathology can more accurately stage bladder cancer and predict who will benefit from additional chemotherapy for patients with suspected bladder tumors.
-
Using ultrasound to improve diagnosis of bladder cancer staging
This study is testing if using a special ultrasound technique can help doctors better determine the stage of bladder cancer in patients who haven't had treatment yet.
-
AI-assisted skin imaging to help nurses spot and stage pressure injuries in ICU patients
We will test whether an AI-assisted mobile app helps ICU nurses more accurately identify and stage pressure injuries in adult ICU patients and whether it boosts their knowledge and confidence.
-
New treatment approach for T4 esophageal cancer
This study is testing a new treatment plan for people with T4 esophageal cancer to see if combining chemotherapy with radiation can help them feel better and live longer.
-
AI-powered sleep staging and sleep apnea screening using multimodal wearable data
This study tests AI models that use wearable and sensor data to help identify sleep stages and screen for obstructive sleep apnea in adults undergoing standard sleep testing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.